Literature DB >> 4912962

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.

H M Perry, E M Tan, S Carmody, A Sakamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4912962

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  54 in total

Review 1.  Reactive metabolites and adverse drug reactions: clinical considerations.

Authors:  Sandra R Knowles; Lori E Shapiro; Neil H Shear
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 2.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 3.  Genetic factors in the predisposition to drug-induced hypersensitivity reactions.

Authors:  Munir Pirmohamed
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 4.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

5.  Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.

Authors:  K Carr; J A Oates; A S Nies; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

6.  Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.

Authors:  C A McQueen; C J Maslansky; I B Glowinski; S B Crescenzi; W W Weber; G M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Antihypertensive effect of diacetolol in essential hypertension.

Authors:  M Thibonnier; C Flabeau; M Thouvenin; A Roux; B Flouvat; P Pasquier; J Menard
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

8.  Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.

Authors:  V Facchini; J A Timbrell
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of dipyrone and its metabolites.

Authors:  M Levy; E Zylber-Katz; B Rosenkranz
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

10.  Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.

Authors:  J Lewalter; U Korallus
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.